Holly Landrum Peay

Dr. Peay is the Director of the Early Check newborn screening study in North Carolina. In addition, Dr. Peay leads research funded by the Food and Drug Administration, National Institutes of Health, not-for-profit foundations, and patient advocacy organizations.

Dr. Peay conducts research related to common and rare disorders with a focus on genetic disorders, newborn screening, and gene therapy/gene editing. Dr. Peay’s research explores the impact and ethical use of emerging technologies such as genome sequencing, ethical considerations related to clinical trials, patient preference and experience, disclosure of research results to participants, and decision support and informed consent tools. Dr. Peay frequently conducts community-engaged research in which she ensures diverse perspectives are included in study planning, implementation, reporting, and the development of recommendations or guidance.

Dr. Peay is Board Certified in genetic counseling by the American Board of Genetic Counseling.